The role of soluble and cell-surface expressed 4-1BB ligand in patients with malignant hemopoietic disorders. (Q51813918)

13 April 2018

title

The role of soluble and cell-surface expressed 4-1BB ligand in patients with malignant hemopoietic disorders. (English)

1 reference

13 April 2018

author name string

Nina Scholl

1

1 reference

13 April 2018

Julia Loibl

2

1 reference

13 April 2018

Andreas Kremser

3

1 reference

13 April 2018

Anja Liepert

4

1 reference

13 April 2018

Christine Grabrucker

5

1 reference

13 April 2018

Helmut Rainer Salih

6

1 reference

13 April 2018

Hans-Jochem Kolb

7

1 reference

13 April 2018

Helga Maria Schmetzer

8

1 reference

13 April 2018

publication date

1 March 2009

1 reference

13 April 2018

published in

Leukemia & Lymphoma

1 reference

13 April 2018

volume

50

1 reference

13 April 2018

issue

3

1 reference

13 April 2018

page(s)

427-436

1 reference

13 April 2018

The TNF and TNF receptor superfamilies: integrating mammalian biology

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Regulation of dendritic cell function by NK cells: mechanisms underlying the synergism in the combination therapy of IL-12 and 4-1BB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

4-1BB-ligand is regulated on human dendritic cells and induces the production of IL-12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

TNF/TNFR family members in costimulation of T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Molecular cloning of a ligand for the inducible T cell gene 4-1BB: a member of an emerging family of cytokines with homology to tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

CD137-induced apoptosis is independent of CD95.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

CD137 and CD137 ligand constitutively coexpressed on human T and B leukemia cells signal proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Soluble CD137 (4-1BB) ligand is released following leukocyte activation and is found in sera of patients with hematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Proposals for the classification of the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Serum levels of CD137 ligand and CD178 are prognostic factors for progression of myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

The use of dendritic cells in cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Generation of mature dendritic cells fully capable of T helper type 1 polarization using OK-432 combined with prostaglandin E(2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Molecular and biological characterization of a murine ligand for CD40

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Molecular and biological characterization of human 4-1BB and its ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

CD28-independent, TRAF2-dependent costimulation of resting T cells by 4-1BB ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Retinoic acid and vitamin E modulate expression and release of CD178 in carcinoma cells: consequences for induction of apoptosis in CD95-sensitive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Fas ligand is highly expressed in acute leukemia and during the transformation of chronic myeloid leukemia to blast crisis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

Identification of regulatory functions for 4-1BB and 4-1BBL in myelopoiesis and the development of dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802709453

10.1080/10428190802709453

21 January 2018

Identifiers

DOI

1 reference

13 April 2018

PubMed ID

19225975

1 reference

13 April 2018